Trademark Search  /  NEXT LEVEL IMMUNO-ONCOLOGY

NEXT LEVEL IMMUNO-ONCOLOGY

● Live · Pending

U.S. federal trademark · Serial No. 97207825

Mark
NEXT LEVEL IMMUNO-ONCOLOGY
Status
Pending
Serial Number
97207825
Filing Date
January 7, 2022
Class(es)
Class 005, Class 042

Owners

Beyond Cancer, Ltd
99 · Garden City, NY, BM
Beyond Cancer, Ltd
99 · Garden City, NY, BM

Goods & Services

Scientific research for medical purposes in the area of tumors, cancer, and respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide and ultra-high nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for tumors, cancer, and respiratory diseases

Pharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes and ultra-high nitric oxide for the treatment of tumors and cancer; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparations for treating tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparations for the treatment of tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "NEXT LEVEL IMMUNO-ONCOLOGY" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.